SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

• Sonia Jangra,
• Chengjin Ye,
• Raveen Rathnasinghe,
• Daniel Stadlbauer,
• Florian Krammer,
• Viviana Simon,
• Luis Martinez-Sobrido,
• Adolfo García-Sastre,
• Michael Schotsaert,
• Hala Alshammary,
• Angela A. Amoako,
• Mahmoud H. Awawda,
• Katherine F Beach,
• Maria C. Bermúdez-González,
• Rachel L. Chernet,
• Lily Q. Eaker,
• Emily D. Ferreri,
• Daniel L. Floda,
• Charles R. Gleason,
• Giulio Kleiner,
• Denise Jurczyszak,
• Julia C. Matthews,
• Wanni A. Mendez,
• Lubbertus C.F. Mulder,
• Kayla T. Russo,
• Ashley-Beathrese T. Salimbangon,
• Miti Saksena,
• Amber S. Shin,
• Levy A. Sominsky,
• Komal Srivastava

Affiliations

Sonia Jangra

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Chengjin Ye

Texas Biomedical Research Institute, San Antonio, TX, USA

Raveen Rathnasinghe

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Daniel Stadlbauer

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Florian Krammer

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Viviana Simon

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Luis Martinez-Sobrido

Texas Biomedical Research Institute, San Antonio, TX, USA

Adolfo García-Sastre

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Michael Schotsaert

Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY 10029, USA

Hala Alshammary

Angela A. Amoako

Mahmoud H. Awawda

Katherine F Beach

Maria C. Bermúdez-González

Rachel L. Chernet

Lily Q. Eaker

Emily D. Ferreri

Daniel L. Floda

Charles R. Gleason

Giulio Kleiner

Denise Jurczyszak

Julia C. Matthews

Wanni A. Mendez

Lubbertus C.F. Mulder

Kayla T. Russo

Ashley-Beathrese T. Salimbangon

Miti Saksena

Amber S. Shin

Levy A. Sominsky

Komal Srivastava